The prevalence of HTLV-III/LAV antibodies among intravenous drug users attending treatment programs in California: a preliminary report.
Levy
N
N
Carlson
J R
JR
Hinrichs
S
S
Lerche
N
N
Schenker
M
M
Gardner
M B
MB
D000163:Acquired Immunodeficiency Syndrome / Q000453:epidemiology / Q000635:transmission; D000914:Antibodies, Viral / Q000032:analysis*; D002140:California; D015483:HIV Antibodies; D006801:Humans; D007275:Injections, Intravenous / Q000009:adverse effects; D019966:Substance-Related Disorders / Q000628:therapy
D000914:Antibodies, Viral; D015483:HIV Antibodies